Delivery Order SPE2DB24D2106-SPE2DB25FAVCK
Award Date
4/23/25
Potential Completion Date
4/24/25
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $2,781.69, is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 17, 2025. DMS Pharmaceutical Group Inc. has a larger indefinite delivery contract (IDC) with the DLA under the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,568,025,980 units of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, with a ceiling value of $4,636.15 and a performance period ending on April 17, 2025. The contract was awarded on April 16, 2025 and is not set aside for any specific program....
This firm fixed-price delivery order was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,040.42 contract is for the supply of 4565900982 - TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, with a period of performance through September 23, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $29,671.36 contract is for the supply of 4,567,316,730 units of the vaccine product TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, with a period of performance through February 6, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $5,563.38, is for the delivery of 4,567,990,624 vials of the TYPHIM VI vaccine. The contract has an ultimate completion date of April 16, 2025 and does not have a set-aside designation. DMS Pharmaceutical Group Inc. is a crucial supplier in the federal pharmaceutical supply chain, holding a $499,999,999 Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Typhim VI 25 mcg/0.5 mL vial, 10 mL, a vaccine product, with a ceiling value of $1,040.42 and a completion date of September 23, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $10,818.60 contract is for the delivery of 4,567,989,735 units of the vaccine TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML. The order has an ultimate completion date of April 17, 2025. DMS Pharmaceutical Group Inc. is the prime contractor and there are no major subcontractors mentioned. This delivery order is part of a larger $499,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $1,854.46, is a delivery order for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 17, 2025. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract has a firm fixed price of $2,080.84 and a completion date of March 28, 2024. It provides for the delivery of 4,564,108,492 units of the Typhim VI influenza vaccine in 10 mL vials. This award is part of a larger $4,999,999 indefinite delivery, indefinite quantity...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $2,080.84 award is for the delivery of 4564096460 Typhim VI 25 mcg/0.5 mL vaccine vials. The contract has no set-aside designation. DMS Pharmaceutical Group holds a larger indefinite delivery contract valued up to $4,999,999 with the DLA under the SPE2DB program, which enables the agency to place...